Solventum Corp. (SOLV)
Operating profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|
Operating income | US$ in thousands | 1,480,000 | 1,693,000 | 1,879,000 | 1,430,000 |
Revenue | US$ in thousands | 8,241,000 | 8,130,000 | 8,171,000 | 7,281,000 |
Operating profit margin | 17.96% | 20.82% | 23.00% | 19.64% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $1,480,000K ÷ $8,241,000K
= 17.96%
Solventum Corp.'s operating profit margin has exhibited a decreasing trend over the past four years. The company's operating profit margin was 17.96% in 2023, down from 20.82% in 2022, 23.00% in 2021, and 19.64% in 2020. This downward trend indicates that the company's ability to generate profits from its core business operations has been weakening over time. Further analysis of Solventum Corp.'s cost management strategies, revenue generation, and operating efficiency may be necessary to understand the factors contributing to this declining trend in operating profit margin.
Peer comparison
Dec 31, 2023
Company name
Symbol
Operating profit margin
Solventum Corp.
SOLV
17.96%
3M Company
MMM
-27.93%
Artivion Inc
AORT
1.73%
Baxter International Inc
BAX
2.63%
Becton Dickinson and Company
BDX
10.90%
Boston Scientific Corp
BSX
16.77%
DexCom Inc
DXCM
16.59%
Embecta Corp
EMBC
19.92%
Glaukos Corp
GKOS
-42.73%
Globus Medical
GMED
8.49%
Haemonetics Corporation
HAE
6.35%